Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

3.7K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
3.7K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

3.8K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.8K
Erythropoiesis01:14

Erythropoiesis

4.9K
Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.9K
Hemoglobin01:24

Hemoglobin

5.2K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
5.2K
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

2.5K
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
2.5K
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

164
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
164

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spectroscopic and solution properties characterization of quaternary ammonium ion containing polycations complexed with fluorescent rhodamine sulfonic acid dyes.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2024
Same author

Modeling hemoglobin levels of patients chronically transfused with red blood cells.

Transfusion·2023
Same author

The oxygen saturation of red blood cell concentrates: The basis for a novel index of red cell oxidative stress.

Transfusion·2021
Same author

Automated system for kinetic analysis of particle size distributions for pharmaceutically relevant systems.

Journal of analytical methods in chemistry·2014
Same author

Probability-based compatibility curves for calcium and phosphates in parenteral nutrition formulations.

JPEN. Journal of parenteral and enteral nutrition·2013
Same author

Interactions between Parenteral Lipid Emulsions and Container Surfaces.

PDA journal of pharmaceutical science and technology·2013

Related Experiment Video

Updated: Oct 1, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.8K

Modelling haemoglobin incremental loss on chronic red blood cell transfusions.

Phillip W Carter1, Andrew J Dunham2

  • 1PC Insights, Barrington, Illinois, USA.

Vox Sanguinis
|March 3, 2022
PubMed
Summary

This study models red blood cell (RBC) lifespan, removal rates, and transfusion intervals to optimize chronic transfusion protocols. Findings show that managing RBC removal (Xe) significantly impacts transfusion frequency and iron exposure in patients.

Keywords:
RBChaemoglobinincrementmodeltransfusion

More Related Videos

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.7K
Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
08:53

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Published on: January 10, 2025

624

Related Experiment Videos

Last Updated: Oct 1, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.8K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.7K
Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
08:53

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Published on: January 10, 2025

624

Area of Science:

  • Hematology
  • Biomedical Engineering
  • Clinical Medicine

Background:

  • Chronic transfusion therapy requires careful management of red blood cell (RBC) lifespan and removal.
  • Optimizing transfusion intervals is crucial for managing patient hemoglobin (Hb) levels and iron overload.
  • Current models lack accessibility for predicting outcomes in chronic transfusion scenarios.

Purpose of the Study:

  • To develop and present a novel model for optimizing chronic transfusion intervals.
  • To analyze the impact of RBC lifespan, initial RBC removal, and transfusion frequency on patient Hb levels.
  • To quantify total iron exposure in patients undergoing chronic transfusion therapy.

Main Methods:

  • Calculated Hb levels and iron exposure using Weibull residual lifespan distributions.
  • Modeled two-unit RBC transfusions initiated at patient Hb of 7 g/dl.
  • Varied RBC lifespans and transfusion intervals (18-90 days), and fractional effete RBC removal (Xe: 0.1-0.5).

Main Results:

  • Increased fractional RBC removal (Xe) necessitates shorter transfusion intervals to maintain target Hb levels (e.g., 30 days for Xe=0.5).
  • Halving RBC lifespan requires adjusted transfusion intervals/Xe pairs to achieve steady-state Hb.
  • Reducing transfused RBC increment loss by 20% decreased annual transfusions by 22% and iron addition by 24%.

Conclusions:

  • Fractional Hb incremental loss (Xe) significantly impacts transfusion intervals and iron introduction.
  • The developed model provides a calculable framework for optimizing chronic transfusion strategies.
  • Findings support informed clinical decisions to minimize transfusion frequency and iron burden.